Literature DB >> 26956036

Constitutive expression of PPARγ inhibits proliferation and migration of gastric cancer cells and down-regulates Wnt/β-Catenin signaling pathway downstream target genes TERT and ENAH.

Fang Guo1, Xiyun Ren2, Yingzi Dong1, Xiaomeng Hu1, Dan Xu3, Haibo Zhou1, Fanyu Meng4, Wenjing Tian5, Yashuang Zhao6.   

Abstract

BACKGROUND: Peroxisome proliferator-activated receptor γ (PPARγ) is a member of the PPAR nuclear hormone receptor superfamily, which plays a crucial role in carcinogenesis. Wnt/β-Catenin signaling pathway has been well certified to contribute to the progression of gastric malignancies. β-Catenin mediates transcriptional regulation by forming a complex with LEF/TCF transcription factors, resulting in activation of downstream target genes such as TERT, ENAH. In this study, we aimed at detecting the effect of PPARγ on TERT, ENAH and explaining the further mechanisms of PPARγ on tumor suppression.
METHODS: The pEGFP-N1-PPARγ recombinant plasmid has already been constructed by researchers in our laboratory. We stably transfected it into three gastric cancer (GC) cell lines (MKN-28, SGC-7901 and BGC-823). CCK-8 and transwell assay were employed to analyze the capability of cell proliferation and metastasis. The mRNA and protein levels were evaluated by real-time PCR and western blot analysis.
RESULTS: After transfected with PPARγ overexpression plasmid, the ability of cell proliferation and migration declined significantly (p<0.05). The expression of PPARγ increased (p<0.05) and β-Catenin was inhibited obviously (p<0.05) in the group of pEGFP-N1-PPARγ plasmid transfection. Meanwhile, the mRNA or protein levels of TERT and ENAH were suppressed (p<0.05) in pEGFP-N1-PPARγ plasmid transfection group compared with control groups.
CONCLUSION: PPARγ might inhibit the proliferation and migration of GC cell lines through suppressing the expression of TERT and ENAH. PPARγ played an important role as a physiological regulator and might be a target for the treatment of GC.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ENAH; Gastric cancer; PPARγ; TERT; Wnt/β-Catenin

Mesh:

Substances:

Year:  2016        PMID: 26956036     DOI: 10.1016/j.gene.2016.03.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

1.  YAP signaling in gastric cancer-derived mesenchymal stem cells is critical for its promoting role in cancer progression.

Authors:  Zhaoji Pan; Yiqing Tian; Bin Zhang; Xu Zhang; Hui Shi; Zhaofeng Liang; Peipei Wu; Rong Li; Benshuai You; Lunyu Yang; Fei Mao; Hui Qian; Wenrong Xu
Journal:  Int J Oncol       Date:  2017-08-23       Impact factor: 5.650

Review 2.  PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.

Authors:  Veronica Vella; Maria Luisa Nicolosi; Stefania Giuliano; Maria Bellomo; Antonino Belfiore; Roberta Malaguarnera
Journal:  Front Endocrinol (Lausanne)       Date:  2017-02-22       Impact factor: 5.555

Review 3.  Peroxisome Proliferator-Activated Receptor γ and PGC-1α in Cancer: Dual Actions as Tumor Promoter and Suppressor.

Authors:  Seong-Hoon Yun; Sang-Heum Han; Joo-In Park
Journal:  PPAR Res       Date:  2018-01-21       Impact factor: 4.964

Review 4.  Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.

Authors:  Alexandre Vallée; Yves Lecarpentier
Journal:  Front Immunol       Date:  2018-04-13       Impact factor: 7.561

5.  Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.

Authors:  Junchi Yang; Lumin Bo; Ting Han; Dan Ding; Mingming Nie; Kai Yin
Journal:  Mol Med Rep       Date:  2018-03-09       Impact factor: 2.952

Review 6.  Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs.

Authors:  Alexandre Vallée; Yves Lecarpentier; Jean-Noël Vallée
Journal:  Cells       Date:  2019-07-15       Impact factor: 6.600

7.  Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?

Authors:  Chiara Cilibrasi; Valentina Butta; Gabriele Riva; Angela Bentivegna
Journal:  PPAR Res       Date:  2016-05-25       Impact factor: 4.964

Review 8.  Research Advances in the Correlation between Peroxisome Proliferator-Activated Receptor-γ and Digestive Cancers.

Authors:  Shuqi Xu; Xuanfu Xu
Journal:  PPAR Res       Date:  2018-02-01       Impact factor: 4.964

9.  NDRG1 was downregulated and worked as favorable biomarker in the development of gastric cancer.

Authors:  Xing-Jun Xiao; Hua-Chuan Zheng
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.